Market and business potential analysis of wound healing products of dermobor

Acute and chronic wounds are critical medical problems throughout the world due to leading serious mortality and morbidity along with economic burden. Acute wounds do not always need professional treatment, but chronic wounds are mainly accompanied by infection resulted in continuous tissue degradation. There are a variety type of wound healing products performed according to the severity of the wound at the moment. Boron containing product Dermobor demonstrated the wound healing effect in vivo and in vitro wound model and it has been newly launched in Turkey. Dermobor enhances acute cutaneous wound healing by preventing infections in wound areas and increasing fibroblast migration, antioxidant enzyme activity, growth factor expression levels. Carbopol-based hydrogel formulated with boron and pluronic block copolymers is also effective for burn wound management with its enhanced epithelization, wound closure, and angiogenesis feature. Treatment with Dermobor also successfully diminished radiation-induced skin reactions. In this study, Dermobor business and market potential researched based on acute and chronic wound healing product sales that has been already in the market. Topical antibacterials, dermotolgical preparation, antiseptics and wound healing ATC classification has been analyzed in this study utilized from IQIVIA databases. The made-up market consisting from those products has increased %18 its value and reached 258 million Turkish Lira in 2018. Considerin the same market for the world data of those market costs 3 billion Euro in value. Consumer behaviour in the pharmacy to the selection a product from those market has been commented on the result of online survey which has 381 respondents. Dermobor positioned as a wound healing product which regenerates tissue and stimulates the healing of: ulcers, wounds, fistulas, burns, inflamations, surgery, grafting, radioepitelitis in various medical specialties.